LENALIDOMIDE

LENALIDOMIDE was reported 425916 times

LENALIDOMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN CHORIONIC GONADOTROPIN INCREASED 597 0.6597
1 PLASMA CELL MYELOMA RECURRENT 1714 0.5272
2 PLASMA CELL LEUKAEMIA 316 0.5267
3 MONOCLONAL IMMUNOGLOBULIN PRESENT 386 0.5079
4 MULTIPLE MYELOMA 2367 0.5074
5 MONOCLONAL IMMUNOGLOBULIN INCREASED 145 0.5070
6 5Q MINUS SYNDROME 80 0.5000
7 PLASMA CELL MYELOMA REFRACTORY 651 0.4865
8 LIGHT CHAIN ANALYSIS INCREASED 484 0.4685
9 B-CELL TYPE ACUTE LEUKAEMIA 331 0.4510
10 PLASMA CELL MYELOMA 17292 0.4428
11 PLASMACYTOMA 731 0.3924
12 FULL BLOOD COUNT DECREASED 7148 0.3544
13 TUMOUR FLARE 237 0.3470
14 MYELODYSPLASTIC SYNDROME TRANSFORMATION 150 0.2879
15 FULL BLOOD COUNT INCREASED 340 0.2855
16 B PRECURSOR TYPE ACUTE LEUKAEMIA 80 0.2062
17 MANTLE CELL LYMPHOMA 267 0.1753
18 PROTEIN TOTAL INCREASED 430 0.1614
19 AMYLOIDOSIS 271 0.1570
20 OSTEOLYSIS 320 0.1564
21 LABORATORY TEST ABNORMAL 4530 0.1533
22 ACUTE LYMPHOCYTIC LEUKAEMIA 428 0.1510
23 MYELODYSPLASTIC SYNDROME 2178 0.1504
24 FOLLICULAR LYMPHOMA 124 0.1409
25 PRODUCT DISTRIBUTION ISSUE 1247 0.1343
26 NEUROPATHY PERIPHERAL 12297 0.1292
27 CARDIAC AMYLOIDOSIS 141 0.1281
28 SQUAMOUS CELL CARCINOMA OF SKIN 766 0.1267
29 DIFFUSE LARGE B-CELL LYMPHOMA 960 0.1245
30 LACTOSE INTOLERANCE 319 0.1244
31 STEM CELL TRANSPLANT 309 0.1236
32 CYTOPENIA 1506 0.1229
33 BONE LESION 436 0.1208
34 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 95 0.1127
35 PNEUMONIA INFLUENZAL 132 0.1108
36 WHITE BLOOD CELL COUNT DECREASED 12018 0.1108
37 ADENOCARCINOMA OF COLON 203 0.1083
38 ACUTE LEUKAEMIA 172 0.1064
39 TREATMENT DELAYED 183 0.1057
40 BLOOD IMMUNOGLOBULIN G INCREASED 128 0.1053
41 PULMONARY THROMBOSIS 1103 0.1011
42 THROMBOSIS 7608 0.0945
43 FEBRILE INFECTION 110 0.0935
44 PLATELET COUNT DECREASED 9655 0.0905
45 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 85 0.0898
46 PARAINFLUENZAE VIRUS INFECTION 134 0.0880
47 TOOTH DISORDER 1920 0.0863
48 HORDEOLUM 371 0.0857
49 WHITE BLOOD CELL DISORDER 226 0.0844
50 RED BLOOD CELL COUNT DECREASED 2414 0.0843
51 ACUTE MYELOID LEUKAEMIA 1305 0.0836
52 PATHOLOGICAL FRACTURE 415 0.0817
53 PROTEIN TOTAL ABNORMAL 105 0.0806
54 BLOOD ELECTROLYTES DECREASED 113 0.0795
55 NEUTROPHIL COUNT DECREASED 3166 0.0776
56 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 167 0.0757
57 BLOOD POTASSIUM DECREASED 2271 0.0755
58 NEUTROPHIL COUNT ABNORMAL 208 0.0735
59 PANCYTOPENIA 4062 0.0726
60 PNEUMONIA PNEUMOCOCCAL 106 0.0715
61 MULTIPLE ALLERGIES 561 0.0715
62 NEUTROPENIA 9518 0.0699
63 FULL BLOOD COUNT ABNORMAL 733 0.0692
64 COVID-19 PNEUMONIA 814 0.0689
65 BLOOD TEST ABNORMAL 963 0.0685
66 HYPOGEUSIA 134 0.0683
67 DEEP VEIN THROMBOSIS 4433 0.0682
68 PLATELET DISORDER 172 0.0681
69 COMPRESSION FRACTURE 365 0.0680
70 RED BLOOD CELL COUNT ABNORMAL 99 0.0673
71 VITAMIN B12 DECREASED 192 0.0666
72 STERNAL FRACTURE 82 0.0665
73 TASTE DISORDER 1330 0.0655
74 HYPERCALCAEMIA 809 0.0655
75 AGEUSIA 1626 0.0651
76 BLOOD COUNT ABNORMAL 987 0.0650
77 HICCUPS 526 0.0640
78 PNEUMONIA LEGIONELLA 101 0.0630
79 B-CELL LYMPHOMA 209 0.0615
80 CANCER PAIN 157 0.0614
81 BLOOD MAGNESIUM DECREASED 529 0.0612
82 WHITE BLOOD CELL COUNT ABNORMAL 387 0.0606
83 IMMUNOGLOBULINS DECREASED 83 0.0604
84 THROMBOCYTOPENIA 6732 0.0601
85 SEASONAL ALLERGY 849 0.0599
86 PULMONARY SEPSIS 87 0.0598
87 PNEUMONIA 19040 0.0588
88 SPINAL COMPRESSION FRACTURE 486 0.0587
89 BLOOD CALCIUM DECREASED 646 0.0574
90 NEOPLASM SKIN 86 0.0553
91 BLOOD CALCIUM ABNORMAL 92 0.0553
92 THROMBOPHLEBITIS SUPERFICIAL 167 0.0551
93 THERAPY INTERRUPTED 3900 0.0545
94 SALMONELLOSIS 91 0.0539
95 BASAL CELL CARCINOMA 839 0.0537
96 BONE MARROW DISORDER 162 0.0536
97 PNEUMONIA VIRAL 170 0.0533
98 PRODUCT PRESCRIBING ISSUE 1159 0.0531
99 FAILURE TO THRIVE 271 0.0521
100 PERIPHERAL SENSORY NEUROPATHY 301 0.0514
101 TUMOUR LYSIS SYNDROME 452 0.0513
102 HAEMOGLOBIN DECREASED 5274 0.0513
103 CONSTIPATION 11201 0.0513
104 PRODUCT SUPPLY ISSUE 365 0.0511
105 BODY HEIGHT DECREASED 544 0.0508
106 LUNG ADENOCARCINOMA 153 0.0508
107 GOUT 910 0.0507
108 JC VIRUS INFECTION 81 0.0506
109 RESPIRATORY SYNCYTIAL VIRUS INFECTION 441 0.0506
110 CORONAVIRUS INFECTION 332 0.0502
111 PROTEIN TOTAL DECREASED 189 0.0501
112 CLOSTRIDIUM DIFFICILE COLITIS 527 0.0497
113 UNEVALUABLE EVENT 3751 0.0495
114 THERAPY PARTIAL RESPONDER 773 0.0495
115 DIARRHOEA 31968 0.0495
116 RASH PRURITIC 2670 0.0492
117 RENAL DISORDER 2290 0.0491
118 DIVERTICULAR PERFORATION 101 0.0490
119 BACK DISORDER 792 0.0487
120 PSEUDOMONAL SEPSIS 85 0.0485
121 SPINAL CORD COMPRESSION 189 0.0485
122 HAEMATOTOXICITY 461 0.0485
123 SPINAL FRACTURE 972 0.0485
124 LOBAR PNEUMONIA 89 0.0480
125 UTERINE DISORDER 112 0.0480
126 LYMPHOMA 738 0.0477
127 RESPIRATORY TRACT INFECTION VIRAL 111 0.0476
128 HYPOGAMMAGLOBULINAEMIA 311 0.0473
129 ESCHERICHIA SEPSIS 137 0.0472
130 POLYNEUROPATHY 564 0.0471
131 EXPOSED BONE IN JAW 102 0.0470
132 CHRONIC LYMPHOCYTIC LEUKAEMIA 223 0.0470
133 ADVERSE DRUG REACTION 4162 0.0463
134 BLOOD POTASSIUM ABNORMAL 122 0.0457
135 VENOUS THROMBOSIS LIMB 93 0.0450
136 ORAL INFECTION 176 0.0450
137 ATRIAL FLUTTER 358 0.0448
138 PERIPHERAL SWELLING 6867 0.0445
139 HAEMATOLOGICAL INFECTION 109 0.0445
140 NEUTROPENIC SEPSIS 311 0.0435
141 MUSCLE SPASMS 7875 0.0429
142 HIP FRACTURE 1378 0.0428
143 GALLBLADDER DISORDER 761 0.0426
144 RASH 18551 0.0425
145 SPINAL DISORDER 401 0.0423
146 CLOSTRIDIUM DIFFICILE INFECTION 924 0.0423
147 ORAL DISORDER 306 0.0417
148 PULMONARY EMBOLISM 3913 0.0411
149 PLATELET COUNT ABNORMAL 248 0.0410
150 IMMUNE SYSTEM DISORDER 537 0.0407
151 NO THERAPEUTIC RESPONSE 495 0.0406
152 PNEUMONIA FUNGAL 160 0.0405
153 CLAVICLE FRACTURE 155 0.0404
154 VENOUS THROMBOSIS 158 0.0402
155 BLOOD DISORDER 322 0.0401
156 EMBOLISM VENOUS 121 0.0399
157 ANAEMIA 7574 0.0397
158 ESCHERICHIA BACTERAEMIA 93 0.0395
159 VIRAL UPPER RESPIRATORY TRACT INFECTION 188 0.0395
160 SQUAMOUS CELL CARCINOMA 370 0.0393
161 EXFOLIATIVE RASH 103 0.0391
162 SEPSIS 4352 0.0390
163 BLOOD CALCIUM INCREASED 342 0.0390
164 RIB FRACTURE 800 0.0389
165 TOOTH INFECTION 512 0.0388
166 GASTROINTESTINAL MOTILITY DISORDER 205 0.0383
167 BONE MARROW FAILURE 769 0.0378
168 EAR SWELLING 80 0.0378
169 COVID-19 6619 0.0377
170 SARS-COV-2 TEST POSITIVE 495 0.0374
171 SKIN DISCOLOURATION 1721 0.0374
172 FEBRILE NEUTROPENIA 2484 0.0374
173 HERPES ZOSTER 2149 0.0374
174 INCREASED TENDENCY TO BRUISE 344 0.0374
175 RHINOVIRUS INFECTION 145 0.0372
176 SECOND PRIMARY MALIGNANCY 309 0.0371
177 MUSCULOSKELETAL CHEST PAIN 571 0.0369
178 LOCALISED INFECTION 892 0.0368
179 UPPER RESPIRATORY TRACT INFECTION 1699 0.0367
180 DISEASE PROGRESSION 4349 0.0367
181 BLOOD IRON DECREASED 436 0.0367
182 PERFORMANCE STATUS DECREASED 170 0.0364
183 CHOLECYSTITIS INFECTIVE 101 0.0363
184 RESPIRATORY TRACT INFECTION 946 0.0363
185 ATRIAL FIBRILLATION 3537 0.0363
186 EMBOLISM 300 0.0361
187 ATYPICAL PNEUMONIA 108 0.0361
188 DRUG INTOLERANCE 3477 0.0360
189 DERMATITIS EXFOLIATIVE GENERALISED 125 0.0359
190 LUMBAR VERTEBRAL FRACTURE 164 0.0358
191 OSTEONECROSIS OF JAW 883 0.0356
192 BLOOD IMMUNOGLOBULIN G DECREASED 88 0.0355
193 LEUKAEMIA 334 0.0354
194 MALIGNANT MELANOMA 473 0.0353
195 CYTOMEGALOVIRUS INFECTION REACTIVATION 154 0.0348
196 FATIGUE 27107 0.0348
197 INSURANCE ISSUE 526 0.0344
198 PRODUCT DOSE OMISSION ISSUE 10080 0.0342
199 TRANSPLANT 81 0.0341
200 DEHYDRATION 4544 0.0340
201 BACTERAEMIA 404 0.0340
202 EYE INFECTION 384 0.0340
203 ADVERSE EVENT 3120 0.0338
204 INFECTION 4897 0.0338
205 BLOOD CREATININE ABNORMAL 117 0.0338
206 HAEMOGLOBIN ABNORMAL 217 0.0337
207 DISEASE COMPLICATION 154 0.0336
208 HUMERUS FRACTURE 162 0.0336
209 PROSTATIC DISORDER 185 0.0335
210 CATARACT 1994 0.0335
211 PELVIC FRACTURE 260 0.0334
212 GINGIVITIS 180 0.0333
213 BRONCHITIS 2466 0.0333
214 RENAL FUNCTION TEST ABNORMAL 154 0.0331
215 THORACIC VERTEBRAL FRACTURE 98 0.0331
216 CYTOKINE RELEASE SYNDROME 660 0.0329
217 INVASIVE DUCTAL BREAST CARCINOMA 89 0.0327
218 THROMBOPHLEBITIS 113 0.0322
219 CERVICAL VERTEBRAL FRACTURE 111 0.0321
220 CELLULITIS 1619 0.0321
221 SEPTIC SHOCK 1395 0.0320
222 VITAMIN D DECREASED 274 0.0320
223 ESCHERICHIA URINARY TRACT INFECTION 136 0.0320
224 METABOLIC ENCEPHALOPATHY 96 0.0320
225 PRODUCT ADMINISTRATION INTERRUPTED 251 0.0319
226 THERAPY CHANGE 314 0.0319
227 RENAL IMPAIRMENT 2675 0.0318
228 HEPATITIS B REACTIVATION 101 0.0318
229 INFLUENZA 3519 0.0315
230 HEARING IMPAIRED 189 0.0315
231 DIVERTICULITIS 873 0.0315
232 BONE DISORDER 574 0.0315
233 CARDIAC DISORDER 2925 0.0312
234 SKIN CANCER 673 0.0312
235 CREATININE RENAL CLEARANCE DECREASED 125 0.0312
236 PAPULE 220 0.0312
237 DEATH 26885 0.0312
238 NAIL DISCOLOURATION 122 0.0310
239 FOOD POISONING 166 0.0310
240 UPPER LIMB FRACTURE 613 0.0307
241 HYPOCALCAEMIA 581 0.0307
242 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 253 0.0306
243 GASTROINTESTINAL TOXICITY 147 0.0306
244 PNEUMONIA BACTERIAL 280 0.0305
245 SINUS DISORDER 604 0.0305
246 RENAL FAILURE 4026 0.0303
247 URINARY TRACT INFECTION 5155 0.0302
248 GASTRIC INFECTION 115 0.0300
249 GASTROINTESTINAL INFECTION 269 0.0300
250 GASTRIC DISORDER 1023 0.0298
251 DEMENTIA 833 0.0298
252 FRACTURE 564 0.0298
253 PRODUCT DISPENSING ISSUE 127 0.0297
254 RASH GENERALISED 766 0.0296
255 ARTHROPATHY 1644 0.0295
256 GRAFT VERSUS HOST DISEASE 212 0.0295
257 PIGMENTATION DISORDER 182 0.0294
258 CARDIAC VALVE DISEASE 168 0.0294
259 UROSEPSIS 269 0.0291
260 MYELOFIBROSIS 88 0.0291
261 GINGIVAL PAIN 231 0.0290
262 PROSTATOMEGALY 114 0.0290
263 HERNIA 559 0.0289
264 BLOOD PHOSPHORUS DECREASED 105 0.0287
265 RASH MACULO-PAPULAR 639 0.0287
266 THROMBOTIC THROMBOCYTOPENIC PURPURA 101 0.0286
267 BONE PAIN 1672 0.0285
268 RESPIRATORY TRACT CONGESTION 452 0.0284
269 MUSCLE STRAIN 245 0.0283
270 STAPHYLOCOCCAL BACTERAEMIA 123 0.0283
271 PRODUCT DOSE OMISSION IN ERROR 801 0.0283
272 DECUBITUS ULCER 229 0.0281
273 ELECTROLYTE IMBALANCE 326 0.0280
274 LYMPHOPENIA 396 0.0280
275 LEUKOPENIA 1387 0.0277
276 IMMUNOSUPPRESSION 243 0.0275
277 JAW DISORDER 150 0.0274
278 NEURALGIA 664 0.0273
279 ASTHENIA 10240 0.0272
280 STAPHYLOCOCCAL SEPSIS 134 0.0271
281 BACTERIAL SEPSIS 88 0.0270
282 OEDEMA PERIPHERAL 3290 0.0270
283 NEOPLASM 310 0.0269
284 NASOPHARYNGITIS 4956 0.0269
285 INTENTIONAL PRODUCT USE ISSUE 2351 0.0268
286 ARTHRITIS INFECTIVE 124 0.0267
287 LUNG INFECTION 415 0.0267
288 OSTEOMYELITIS 482 0.0266
289 VIRAL INFECTION 883 0.0265
290 NERVE INJURY 295 0.0265
291 DECREASED APPETITE 6159 0.0265
292 LOOSE TOOTH 85 0.0264
293 GINGIVAL DISORDER 101 0.0262
294 HAEMORRHOIDAL HAEMORRHAGE 128 0.0262
295 CARDIAC FAILURE CONGESTIVE 2104 0.0262
296 AORTIC STENOSIS 91 0.0261
297 TOOTH ABSCESS 263 0.0258
298 APPETITE DISORDER 170 0.0256
299 FEBRILE BONE MARROW APLASIA 108 0.0254
300 HYPOAESTHESIA 3788 0.0253
301 ORAL PAIN 565 0.0252
302 GASTROINTESTINAL DISORDER 2242 0.0250
303 TRANSIENT ISCHAEMIC ATTACK 841 0.0249
304 GASTROENTERITIS VIRAL 450 0.0249
305 BRONCHOPULMONARY ASPERGILLOSIS 190 0.0245
306 RASH VESICULAR 118 0.0244
307 BOWEL MOVEMENT IRREGULARITY 186 0.0243
308 IMMUNODEFICIENCY 361 0.0242
309 NIGHT SWEATS 779 0.0242
310 HYPOACUSIS 1033 0.0240
311 CLOSTRIDIAL INFECTION 81 0.0239
312 HYPOKALAEMIA 1105 0.0239
313 PHLEBITIS 122 0.0238
314 COLITIS ISCHAEMIC 160 0.0237
315 ARTHRITIS BACTERIAL 97 0.0236
316 ESCHERICHIA INFECTION 194 0.0236
317 LARGE INTESTINE PERFORATION 163 0.0234
318 BLOOD PRESSURE ABNORMAL 465 0.0234
319 SINUSITIS 2391 0.0233
320 GINGIVAL SWELLING 103 0.0233
321 PERIPHERAL COLDNESS 320 0.0233
322 DERMATITIS ALLERGIC 293 0.0233
323 BACK PAIN 5405 0.0232
324 FLUID RETENTION 1180 0.0232
325 FAECALOMA 127 0.0232
326 HYPOPHOSPHATAEMIA 170 0.0230
327 COLON CANCER 342 0.0229
328 UPPER-AIRWAY COUGH SYNDROME 189 0.0229
329 FALL 7613 0.0229
330 RENAL FAILURE CHRONIC 175 0.0227
331 COLITIS 855 0.0225
332 GUILLAIN-BARRE SYNDROME 109 0.0225
333 JOINT SWELLING 2717 0.0225
334 TOXIC SKIN ERUPTION 226 0.0224
335 ORTHOSTATIC HYPOTENSION 390 0.0224
336 BLOOD CREATINE INCREASED 99 0.0223
337 FUNGAL SKIN INFECTION 90 0.0223
338 TOOTHACHE 401 0.0221
339 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 567 0.0220
340 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 84 0.0220
341 SKIN TOXICITY 124 0.0219
342 PRODUCT DOSE OMISSION 1432 0.0219
343 OFF LABEL USE 19177 0.0219
344 ARTHROPOD BITE 162 0.0218
345 ANGIOPATHY 122 0.0217
346 MENINGITIS 145 0.0217
347 HYPERURICAEMIA 89 0.0216
348 MASS 302 0.0216
349 GINGIVAL BLEEDING 295 0.0216
350 HAEMATOCRIT DECREASED 426 0.0215
351 INGUINAL HERNIA 130 0.0213
352 MYELOSUPPRESSION 769 0.0213
353 BRAIN FOG 334 0.0213
354 PYREXIA 7352 0.0212
355 HYPOALBUMINAEMIA 165 0.0212
356 ACUTE RESPIRATORY FAILURE 408 0.0212
357 EYE DISORDER 695 0.0211
358 POOR PERIPHERAL CIRCULATION 90 0.0211
359 PULMONARY OEDEMA 946 0.0211
360 BACTERIAL INFECTION 391 0.0209
361 RASH MACULAR 732 0.0209
362 LOWER LIMB FRACTURE 402 0.0209
363 CHOLECYSTITIS ACUTE 118 0.0208
364 FURUNCLE 165 0.0208
365 CYSTITIS 662 0.0208
366 SKIN INFECTION 233 0.0207
367 EAR DISORDER 95 0.0207
368 STOMATITIS 1257 0.0207
369 ONYCHOCLASIS 142 0.0206
370 THROMBOTIC MICROANGIOPATHY 201 0.0206
371 BLOOD CREATININE INCREASED 1342 0.0205
372 SWELLING FACE 1332 0.0204
373 PNEUMOCYSTIS JIROVECII PNEUMONIA 203 0.0202
374 MUSCULOSKELETAL DISORDER 384 0.0202
375 SKIN ATROPHY 115 0.0200
376 CARDIAC FAILURE 1596 0.0199
377 PLEURAL EFFUSION 1208 0.0198
378 DEAFNESS 519 0.0198
379 MELANOCYTIC NAEVUS 87 0.0198
380 CONTUSION 1909 0.0198
381 RHINORRHOEA 1279 0.0198
382 BLADDER DISORDER 196 0.0197
383 SKIN HYPERPIGMENTATION 169 0.0196
384 PRURITUS 7546 0.0196
385 LIMB DISCOMFORT 607 0.0196
386 ATELECTASIS 189 0.0195
387 ILLNESS 2008 0.0195
388 HAEMORRHOIDS 380 0.0195
389 RESPIRATORY FAILURE 1417 0.0194
390 HEPATITIS B 117 0.0194
391 ILEUS 241 0.0194
392 APPENDICITIS 181 0.0194
393 DYSGEUSIA 1436 0.0193
394 OEDEMA 1040 0.0192
395 PARAESTHESIA 3015 0.0191
396 SCIATICA 304 0.0191
397 KIDNEY INFECTION 374 0.0190
398 ILEUS PARALYTIC 85 0.0190
399 MALNUTRITION 213 0.0190
400 RESPIRATION ABNORMAL 131 0.0190
401 LIMB INJURY 516 0.0190
402 SPINAL PAIN 222 0.0189
403 HYPOTENSION 3796 0.0189
404 TREATMENT NONCOMPLIANCE 1035 0.0189
405 BLOOD SODIUM DECREASED 356 0.0189
406 SKIN ULCER 488 0.0189
407 DRUG ERUPTION 334 0.0188
408 DYSPHONIA 1102 0.0188
409 FAECES SOFT 137 0.0188
410 BALANCE DISORDER 1622 0.0187
411 ENTEROCOLITIS 108 0.0187
412 HOSPITALISATION 2873 0.0187
413 HEPATIC ENZYME ABNORMAL 93 0.0186
414 ADVERSE REACTION 247 0.0186
415 SKIN DISORDER 621 0.0186
416 CARDIAC FAILURE ACUTE 124 0.0186
417 CYST 230 0.0185
418 VARICOSE VEIN 95 0.0184
419 CANDIDA INFECTION 309 0.0183
420 DIVERTICULUM 130 0.0183
421 MENTAL STATUS CHANGES 508 0.0183
422 HYPOPHAGIA 466 0.0182
423 SKIN ABRASION 86 0.0182
424 WEIGHT FLUCTUATION 190 0.0181
425 TUMOUR MARKER INCREASED 87 0.0181
426 LYMPHOEDEMA 125 0.0181
427 WEIGHT DECREASED 5046 0.0181
428 SMALL INTESTINAL OBSTRUCTION 222 0.0180
429 ACUTE PULMONARY OEDEMA 101 0.0180
430 RENAL FAILURE ACUTE 761 0.0179
431 SPLENOMEGALY 210 0.0179
432 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 934 0.0179
433 NEPHROPATHY 167 0.0179
434 THERAPY NON-RESPONDER 804 0.0179
435 ACUTE MYOCARDIAL INFARCTION 527 0.0179
436 DRY SKIN 2377 0.0178
437 EOSINOPHILIA 312 0.0178
438 FEMORAL NECK FRACTURE 91 0.0177
439 ACUTE CORONARY SYNDROME 147 0.0177
440 ENDOCARDITIS 91 0.0177
441 LUNG INFILTRATION 156 0.0176
442 FEELING JITTERY 336 0.0176
443 SKIN LESION 482 0.0176
444 CHOLECYSTITIS 208 0.0174
445 FLATULENCE 990 0.0174
446 SYNCOPE 1743 0.0174
447 INTESTINAL OBSTRUCTION 653 0.0173
448 BLOOD URINE PRESENT 328 0.0173
449 PERIPHERAL VASCULAR DISORDER 89 0.0173
450 EPISTAXIS 1291 0.0172
451 BENIGN PROSTATIC HYPERPLASIA 89 0.0172
452 CEREBROVASCULAR ACCIDENT 2912 0.0172
453 MALIGNANT NEOPLASM PROGRESSION 1757 0.0171
454 ORGANISING PNEUMONIA 85 0.0171
455 SPINAL COLUMN STENOSIS 81 0.0171
456 TROPONIN INCREASED 130 0.0171
457 LYMPHOCYTE COUNT DECREASED 302 0.0171
458 MULTIPLE ORGAN DYSFUNCTION SYNDROME 483 0.0170
459 TREMOR 2830 0.0170
460 ABDOMINAL DISCOMFORT 2857 0.0170
461 ISCHAEMIC STROKE 302 0.0169
462 PNEUMONITIS 460 0.0169
463 HYPERSOMNIA 480 0.0167
464 STAPHYLOCOCCAL INFECTION 550 0.0167
465 RESPIRATORY DISORDER 497 0.0166
466 NERVE COMPRESSION 153 0.0166
467 ATRIOVENTRICULAR BLOCK 128 0.0165
468 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 98 0.0165
469 PULMONARY MASS 246 0.0165
470 MEMORY IMPAIRMENT 2268 0.0165
471 PETECHIAE 172 0.0165
472 APHONIA 230 0.0165
473 FEMUR FRACTURE 508 0.0164
474 TOXICITY TO VARIOUS AGENTS 2764 0.0164
475 RENAL CELL CARCINOMA 80 0.0163
476 SWELLING 1528 0.0163
477 GENERALISED OEDEMA 202 0.0163
478 PURPURA 144 0.0163
479 HYPOAESTHESIA ORAL 245 0.0162
480 PROTEIN URINE PRESENT 81 0.0162
481 LOWER RESPIRATORY TRACT INFECTION 738 0.0162
482 GASTROENTERITIS 236 0.0162
483 PLEURISY 96 0.0162
484 COUGH 4529 0.0161
485 EAR DISCOMFORT 165 0.0161
486 SUDDEN DEATH 170 0.0160
487 EAR INFECTION 427 0.0160
488 PERICARDIAL EFFUSION 370 0.0160
489 TOOTH FRACTURE 176 0.0159
490 HYPERGLYCAEMIA 581 0.0159
491 HEAD INJURY 504 0.0159
492 SKIN LACERATION 173 0.0159
493 DENTAL CARIES 175 0.0158
494 INSOMNIA 4207 0.0158
495 MUCOSAL INFLAMMATION 413 0.0158
496 EYE SWELLING 586 0.0157
497 DIARRHOEA HAEMORRHAGIC 147 0.0157
498 NEPHROLITHIASIS 718 0.0156
499 ACUTE KIDNEY INJURY 2385 0.0156
500 PAROSMIA 117 0.0155
501 COGNITIVE DISORDER 724 0.0155
502 MULTI-ORGAN FAILURE 267 0.0154
503 THYROID DISORDER 238 0.0154
504 FEEDING DISORDER 313 0.0154
505 CYTOMEGALOVIRUS INFECTION 256 0.0154
506 HYPOVOLAEMIA 90 0.0154
507 SKIN REACTION 216 0.0153
508 RASH ERYTHEMATOUS 730 0.0153
509 ROTATOR CUFF SYNDROME 196 0.0152
510 MACULAR DEGENERATION 182 0.0152
511 DEVICE RELATED INFECTION 234 0.0152
512 LIVER DISORDER 672 0.0151
513 LUNG DISORDER 741 0.0151
514 INCONTINENCE 159 0.0150
515 HYPOMAGNESAEMIA 209 0.0150
516 HEART RATE IRREGULAR 339 0.0150
517 SLUGGISHNESS 153 0.0150
518 CONFUSIONAL STATE 2413 0.0149
519 LYMPHADENOPATHY 528 0.0149
520 PHARYNGITIS 185 0.0149
521 HOSPICE CARE 147 0.0149
522 AMNESIA 965 0.0148
523 DIZZINESS 7375 0.0148
524 NEOPLASM PROGRESSION 513 0.0147
525 SKIN EXFOLIATION 1244 0.0147
526 CARDIAC FLUTTER 95 0.0147
527 SUBDURAL HAEMATOMA 210 0.0147
528 BLOOD POTASSIUM INCREASED 236 0.0145
529 BACK INJURY 158 0.0145
530 ASPERGILLUS INFECTION 95 0.0145
531 DRY EYE 722 0.0144
532 DIZZINESS POSTURAL 140 0.0144
533 ABDOMINAL PAIN UPPER 2970 0.0144
534 BLOOD LACTATE DEHYDROGENASE INCREASED 228 0.0144
535 ORAL CANDIDIASIS 188 0.0143
536 LOCAL SWELLING 249 0.0143
537 EATING DISORDER 303 0.0142
538 HEART RATE DECREASED 497 0.0141
539 SINUS CONGESTION 191 0.0141
540 LIVER FUNCTION TEST INCREASED 303 0.0141
541 INTERNAL HAEMORRHAGE 161 0.0141
542 PRODUCTIVE COUGH 671 0.0140
543 ANOSMIA 203 0.0140
544 GENERAL PHYSICAL CONDITION ABNORMAL 95 0.0140
545 CARDIOMYOPATHY 207 0.0140
546 HYPOXIA 492 0.0140
547 CHOLELITHIASIS 458 0.0140
548 PAIN IN EXTREMITY 4110 0.0139
549 INTERVERTEBRAL DISC DEGENERATION 129 0.0139
550 LACERATION 131 0.0139
551 NAUSEA 10998 0.0139
552 LACRIMATION INCREASED 419 0.0139
553 CEREBRAL DISORDER 102 0.0138
554 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 107 0.0138
555 SPINAL OSTEOARTHRITIS 121 0.0138
556 OROPHARYNGEAL PAIN 1274 0.0137
557 ECCHYMOSIS 94 0.0137
558 SWELLING OF EYELID 86 0.0137
559 DYSPNOEA 7743 0.0137
560 INTESTINAL PERFORATION 153 0.0136
561 WOUND INFECTION 149 0.0136
562 DYSPNOEA EXERTIONAL 512 0.0136
563 ULCER 216 0.0136
564 SENSITIVE SKIN 100 0.0135
565 ARRHYTHMIA 641 0.0135
566 HAEMOLYTIC ANAEMIA 121 0.0135
567 WOUND 377 0.0135
568 HAIR GROWTH ABNORMAL 93 0.0134
569 GAIT INABILITY 449 0.0134
570 POLLAKIURIA 559 0.0134
571 LIGAMENT SPRAIN 132 0.0133
572 LETHARGY 763 0.0132
573 TENDERNESS 138 0.0132
574 CARDIOTOXICITY 118 0.0132
575 FLUID OVERLOAD 192 0.0132
576 EYE DISCHARGE 137 0.0132
577 SUPRAVENTRICULAR TACHYCARDIA 126 0.0131
578 BLOOD TESTOSTERONE DECREASED 90 0.0131
579 GLAUCOMA 253 0.0131
580 HYPERTHERMIA 100 0.0131
581 WRIST FRACTURE 157 0.0131
582 GASTROINTESTINAL PAIN 144 0.0131
583 INFUSION RELATED REACTION 863 0.0130
584 AORTIC ANEURYSM 99 0.0130
585 FUNGAL INFECTION 433 0.0130
586 DRY MOUTH 1054 0.0130
587 MYOCARDIAL INFARCTION 2263 0.0130
588 TRICUSPID VALVE INCOMPETENCE 103 0.0130
589 NECK PAIN 724 0.0129
590 DYSPEPSIA 1274 0.0129
591 PNEUMONIA ASPIRATION 323 0.0129
592 URINE OUTPUT DECREASED 113 0.0129
593 PAIN IN JAW 366 0.0129
594 FLANK PAIN 121 0.0129
595 DRY THROAT 131 0.0129
596 PLATELET COUNT INCREASED 168 0.0129
597 SKIN MASS 86 0.0129
598 JOINT INJURY 275 0.0129
599 ANKLE FRACTURE 199 0.0128
600 BODY TEMPERATURE INCREASED 262 0.0128
601 URTICARIA 2148 0.0128
602 FOOT FRACTURE 243 0.0128
603 EMPHYSEMA 129 0.0128
604 GENERAL PHYSICAL HEALTH DETERIORATION 1470 0.0127
605 FAECES DISCOLOURED 273 0.0126
606 RHINITIS 101 0.0125
607 VISION BLURRED 1719 0.0125
608 ACUTE RESPIRATORY DISTRESS SYNDROME 221 0.0125
609 MITRAL VALVE INCOMPETENCE 141 0.0124
610 ANAL INCONTINENCE 112 0.0124
611 CHEST PAIN 2303 0.0124
612 POST PROCEDURAL INFECTION 101 0.0124
613 ULCER HAEMORRHAGE 84 0.0124
614 PULMONARY HAEMORRHAGE 97 0.0124
615 URINARY RETENTION 413 0.0124
616 HEPATIC ENZYME INCREASED 840 0.0123
617 GROIN PAIN 108 0.0123
618 BLISTER 689 0.0123
619 LOSS OF CONSCIOUSNESS 1565 0.0122
620 PRESYNCOPE 296 0.0122
621 HAEMOPTYSIS 339 0.0121
622 EAR PAIN 236 0.0121
623 CHILLS 1423 0.0121
624 ABDOMINAL DISTENSION 1261 0.0121
625 MYOPATHY 104 0.0120
626 BURSITIS 146 0.0120
627 MUSCULAR WEAKNESS 1362 0.0120
628 RENAL CYST 95 0.0119
629 NEPHROPATHY TOXIC 134 0.0119
630 TINNITUS 548 0.0119
631 CORONARY ARTERY DISEASE 361 0.0119
632 CARDIOMEGALY 146 0.0119
633 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 113 0.0118
634 DYSURIA 435 0.0118
635 RASH PAPULAR 263 0.0117
636 MALAISE 5146 0.0117
637 CARDIAC ARREST 967 0.0117
638 C-REACTIVE PROTEIN INCREASED 426 0.0117
639 MUSCLE TIGHTNESS 189 0.0117
640 STEVENS-JOHNSON SYNDROME 259 0.0116
641 FACIAL PARALYSIS 99 0.0116
642 EXOSTOSIS 106 0.0116
643 ARTHRITIS 913 0.0116
644 MYOCARDITIS 133 0.0116
645 JOINT EFFUSION 80 0.0116
646 NEUROTOXICITY 203 0.0116
647 VASCULITIS 134 0.0115
648 IRRITABLE BOWEL SYNDROME 246 0.0115
649 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 86 0.0114
650 HYPERSENSITIVITY 2115 0.0114
651 MOUTH HAEMORRHAGE 83 0.0113
652 BLOOD BILIRUBIN INCREASED 305 0.0113
653 GASTRIC ULCER 214 0.0112
654 RECTAL HAEMORRHAGE 482 0.0112
655 BLOOD ALBUMIN DECREASED 89 0.0112
656 PRODUCT PHYSICAL ISSUE 226 0.0112
657 RESTLESS LEGS SYNDROME 203 0.0112
658 INTERVERTEBRAL DISC PROTRUSION 244 0.0112
659 ARTERIOSCLEROSIS 105 0.0111
660 ACCIDENT 133 0.0111
661 HAEMOLYSIS 86 0.0111
662 HAEMATOCHEZIA 612 0.0111
663 POOR QUALITY SLEEP 238 0.0110
664 NOCTURIA 134 0.0110
665 NAIL DISORDER 96 0.0110
666 CEREBRAL HAEMORRHAGE 392 0.0109
667 BRAIN NEOPLASM 100 0.0109
668 MOUTH ULCERATION 229 0.0109
669 FEELING ABNORMAL 2603 0.0109
670 ABASIA 268 0.0108
671 CONJUNCTIVITIS 201 0.0108
672 NERVOUSNESS 565 0.0108
673 CARPAL TUNNEL SYNDROME 151 0.0108
674 ABSCESS 172 0.0108
675 INTENTIONAL DOSE OMISSION 307 0.0108
676 PARAESTHESIA ORAL 155 0.0107
677 VOMITING 5046 0.0107
678 PSEUDOMONAS INFECTION 92 0.0107
679 HYPERBILIRUBINAEMIA 111 0.0107
680 DYSPHAGIA 1014 0.0107
681 THERAPY CESSATION 548 0.0107
682 INABILITY TO AFFORD MEDICATION 106 0.0107
683 DIABETES MELLITUS 813 0.0107
684 RENAL PAIN 113 0.0106
685 PULMONARY FIBROSIS 204 0.0106
686 HAEMORRHAGE 1111 0.0106
687 PULMONARY CONGESTION 140 0.0106
688 RESPIRATORY DISTRESS 293 0.0106
689 ERYTHEMA MULTIFORME 99 0.0106
690 WHITE BLOOD CELL COUNT INCREASED 407 0.0106
691 NASAL CONGESTION 621 0.0106
692 EJECTION FRACTION DECREASED 164 0.0105
693 ENCEPHALOPATHY 259 0.0105
694 GASTRITIS 277 0.0105
695 MUSCULOSKELETAL DISCOMFORT 181 0.0105
696 EYE HAEMORRHAGE 140 0.0105
697 BURNING SENSATION 735 0.0105
698 PRODUCT DISPENSING ERROR 228 0.0105
699 GASTROOESOPHAGEAL REFLUX DISEASE 840 0.0104
700 BLOOD PRESSURE DECREASED 693 0.0104
701 SNEEZING 233 0.0104
702 LIVER FUNCTION TEST ABNORMAL 302 0.0104
703 FACE OEDEMA 175 0.0104
704 DISSEMINATED INTRAVASCULAR COAGULATION 146 0.0104
705 SINUS BRADYCARDIA 100 0.0103
706 CONCUSSION 80 0.0103
707 GASTROINTESTINAL HAEMORRHAGE 863 0.0103
708 APHTHOUS ULCER 80 0.0103
709 INCREASED APPETITE 196 0.0102
710 FEELING COLD 283 0.0102
711 CHROMATURIA 229 0.0101
712 HEPATIC CYTOLYSIS 128 0.0100
713 PAIN 6157 0.0100
714 TOXIC EPIDERMAL NECROLYSIS 152 0.0100
715 GLOMERULAR FILTRATION RATE DECREASED 123 0.0100
716 DELIRIUM 347 0.0100
717 CARDIAC MURMUR 86 0.0099
718 HIATUS HERNIA 128 0.0099
719 NEOPLASM MALIGNANT 658 0.0098
720 NERVOUS SYSTEM DISORDER 307 0.0098
721 HYPERHIDROSIS 1266 0.0098
722 DERMATITIS CONTACT 112 0.0098
723 HYPONATRAEMIA 553 0.0098
724 MUSCULOSKELETAL STIFFNESS 860 0.0098
725 MUSCLE ATROPHY 124 0.0098
726 VITREOUS FLOATERS 96 0.0098
727 MYALGIA 1659 0.0097
728 DRUG DOSE OMISSION 1611 0.0097
729 PHARYNGITIS STREPTOCOCCAL 105 0.0097
730 RETINAL DETACHMENT 89 0.0097
731 DECREASED IMMUNE RESPONSIVENESS 95 0.0097
732 SLEEP DISORDER 680 0.0096
733 ABDOMINAL PAIN 2225 0.0096
734 DISORIENTATION 379 0.0096
735 JOINT DISLOCATION 101 0.0095
736 SOMNOLENCE 1918 0.0095
737 VERTIGO 580 0.0095
738 PROSTATIC SPECIFIC ANTIGEN INCREASED 131 0.0095
739 AGRANULOCYTOSIS 176 0.0095
740 OESOPHAGITIS 103 0.0094
741 MUSCULOSKELETAL PAIN 489 0.0093
742 ARTHRALGIA 3867 0.0093
743 DERMATITIS 194 0.0092
744 PRURITUS GENERALISED 200 0.0092
745 HOT FLUSH 697 0.0092
746 VENTRICULAR EXTRASYSTOLES 96 0.0092
747 HEPATIC FUNCTION ABNORMAL 345 0.0092
748 PNEUMOTHORAX 146 0.0092
749 SCAB 105 0.0092
750 CARDIOGENIC SHOCK 132 0.0092
751 RENAL TUBULAR NECROSIS 90 0.0092
752 HAEMATURIA 314 0.0092
753 PULMONARY HYPERTENSION 190 0.0091
754 QUALITY OF LIFE DECREASED 122 0.0091
755 DIPLOPIA 236 0.0091
756 IMPAIRED HEALING 298 0.0091
757 HAEMATOMA 235 0.0091
758 MULTIPLE FRACTURES 149 0.0091
759 INTERNATIONAL NORMALISED RATIO INCREASED 258 0.0090
760 GAIT DISTURBANCE 1729 0.0090
761 ADRENAL INSUFFICIENCY 108 0.0089
762 VISUAL IMPAIRMENT 1102 0.0089
763 CARDIOVASCULAR DISORDER 224 0.0088
764 ROAD TRAFFIC ACCIDENT 368 0.0088
765 HEPATOMEGALY 86 0.0087
766 HYPERTENSION 1853 0.0087
767 CEREBRAL INFARCTION 212 0.0087
768 ASPIRATION 95 0.0087
769 MICTURITION URGENCY 99 0.0087
770 VENTRICULAR TACHYCARDIA 142 0.0086
771 WEIGHT INCREASED 1919 0.0086
772 ORAL DISCOMFORT 119 0.0086
773 URINARY INCONTINENCE 253 0.0085
774 PERICARDITIS 142 0.0084
775 ANGINA PECTORIS 242 0.0084
776 MYOCARDIAL ISCHAEMIA 96 0.0084
777 OSTEOPENIA 128 0.0084
778 OSTEOPOROSIS 346 0.0084
779 BLOOD GLUCOSE ABNORMAL 155 0.0084
780 SECRETION DISCHARGE 105 0.0084
781 HYPERKALAEMIA 294 0.0084
782 HYPOTHYROIDISM 267 0.0084
783 HEPATIC FAILURE 252 0.0084
784 HEAD DISCOMFORT 147 0.0083
785 INFLUENZA LIKE ILLNESS 682 0.0083
786 BLOOD UREA INCREASED 138 0.0082
787 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 192 0.0082
788 HAEMORRHAGE INTRACRANIAL 123 0.0082
789 HYPERLIPIDAEMIA 98 0.0082
790 LUNG NEOPLASM MALIGNANT 336 0.0082
791 FREQUENT BOWEL MOVEMENTS 220 0.0081
792 INTERSTITIAL LUNG DISEASE 392 0.0081
793 APHASIA 244 0.0081
794 PSYCHOMOTOR HYPERACTIVITY 133 0.0080
795 THIRST 143 0.0080
796 HEPATOTOXICITY 177 0.0079
797 ORAL HERPES 155 0.0079
798 CARDIO-RESPIRATORY ARREST 329 0.0079
799 THERAPEUTIC RESPONSE DECREASED 473 0.0078
800 TOOTH EXTRACTION 97 0.0078
801 JAUNDICE 209 0.0078
802 SKIN HAEMORRHAGE 115 0.0078
803 GASTRIC HAEMORRHAGE 89 0.0077
804 OCULAR HYPERAEMIA 367 0.0077
805 THERAPEUTIC PRODUCT EFFECT DECREASED 341 0.0076
806 DIALYSIS 108 0.0076
807 FEELING HOT 466 0.0076
808 NODULE 99 0.0076
809 ATAXIA 89 0.0075
810 BRADYCARDIA 397 0.0075
811 THYROID CANCER 90 0.0075
812 INFLAMMATION 385 0.0075
813 ALOPECIA 1451 0.0074
814 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 249 0.0074
815 ALANINE AMINOTRANSFERASE INCREASED 452 0.0074
816 ERYTHEMA 1501 0.0073
817 LIP SWELLING 242 0.0073
818 PARALYSIS 104 0.0073
819 DISEASE RECURRENCE 344 0.0072
820 PHOTOSENSITIVITY REACTION 119 0.0072
821 HEPATOCELLULAR INJURY 102 0.0072
822 HEPATITIS 184 0.0072
823 OSTEOARTHRITIS 304 0.0072
824 DRUG RESISTANCE 184 0.0072
825 CORONARY ARTERY OCCLUSION 98 0.0071
826 OSTEONECROSIS 234 0.0071
827 JOINT STIFFNESS 186 0.0071
828 MELAENA 156 0.0071
829 MOOD ALTERED 193 0.0071
830 EYELID OEDEMA 82 0.0070
831 CHOLESTASIS 135 0.0070
832 ERECTILE DYSFUNCTION 180 0.0070
833 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1259 0.0070
834 BLOOD PRESSURE FLUCTUATION 167 0.0070
835 PANCREATITIS 367 0.0069
836 BLOOD GLUCOSE DECREASED 333 0.0069
837 DYSSTASIA 202 0.0069
838 HEART RATE INCREASED 684 0.0069
839 TOOTH LOSS 143 0.0069
840 BLOOD ALKALINE PHOSPHATASE INCREASED 171 0.0069
841 HEADACHE 4312 0.0069
842 HEPATITIS C 83 0.0069
843 LEUKOCYTOSIS 124 0.0068
844 HYPERTHYROIDISM 99 0.0068
845 ASCITES 201 0.0068
846 BLINDNESS 278 0.0068
847 TRANSAMINASES INCREASED 151 0.0068
848 SINUS TACHYCARDIA 96 0.0068
849 COLD SWEAT 119 0.0067
850 PRESCRIBED UNDERDOSE 134 0.0067
851 GLOSSODYNIA 150 0.0067
852 PRODUCT USE ISSUE 1257 0.0067
853 PRODUCT SUBSTITUTION ISSUE 385 0.0067
854 PROTEINURIA 127 0.0067
855 ANOREXIA 86 0.0067
856 HAEMATEMESIS 169 0.0067
857 METASTASES TO BONE 109 0.0066
858 CIRCULATORY COLLAPSE 113 0.0066
859 CHEST DISCOMFORT 679 0.0066
860 SWOLLEN TONGUE 207 0.0066
861 END STAGE RENAL DISEASE 120 0.0066
862 COAGULOPATHY 109 0.0065
863 DEPRESSION 1483 0.0065
864 ALTERED STATE OF CONSCIOUSNESS 141 0.0065
865 SEIZURE 747 0.0065
866 TENDONITIS 100 0.0065
867 BLOOD PRESSURE INCREASED 975 0.0064
868 ASPARTATE AMINOTRANSFERASE INCREASED 335 0.0063
869 SLEEP APNOEA SYNDROME 120 0.0063
870 MENTAL IMPAIRMENT 151 0.0062
871 BLOOD GLUCOSE INCREASED 1173 0.0062
872 EYE PRURITUS 209 0.0062
873 HALLUCINATION 466 0.0062
874 THROAT IRRITATION 275 0.0061
875 THINKING ABNORMAL 114 0.0061
876 SHOCK 139 0.0060
877 HEPATIC STEATOSIS 112 0.0060
878 PROSTATE CANCER 482 0.0060
879 PERITONITIS 124 0.0060
880 TREATMENT FAILURE 495 0.0060
881 OXYGEN SATURATION DECREASED 335 0.0060
882 DISTURBANCE IN ATTENTION 320 0.0059
883 MENTAL DISORDER 257 0.0059
884 PANCREATITIS ACUTE 132 0.0059
885 RETCHING 125 0.0059
886 BONE LOSS 88 0.0058
887 TACHYCARDIA 518 0.0058
888 SPEECH DISORDER 305 0.0058
889 TUBULOINTERSTITIAL NEPHRITIS 109 0.0058
890 ANXIETY 1644 0.0058
891 UPPER GASTROINTESTINAL HAEMORRHAGE 97 0.0058
892 PHARYNGEAL OEDEMA 87 0.0056
893 ABDOMINAL PAIN LOWER 143 0.0056
894 ERUCTATION 109 0.0056
895 ASTHMA 626 0.0055
896 PAIN OF SKIN 149 0.0055
897 CHRONIC KIDNEY DISEASE 419 0.0055
898 HEPATIC CIRRHOSIS 103 0.0055
899 ELECTROCARDIOGRAM QT PROLONGED 197 0.0055
900 POST PROCEDURAL COMPLICATION 105 0.0055
901 UNRESPONSIVE TO STIMULI 141 0.0055
902 MOOD SWINGS 174 0.0055
903 PALPITATIONS 637 0.0054
904 IRRITABILITY 327 0.0054
905 MOVEMENT DISORDER 174 0.0054
906 VISUAL ACUITY REDUCED 179 0.0054
907 BLOOD CHOLESTEROL INCREASED 251 0.0054
908 HEMIPARESIS 91 0.0054
909 RESTLESSNESS 196 0.0054
910 DYSARTHRIA 200 0.0053
911 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 254 0.0053
912 BREAST CANCER 488 0.0052
913 PRODUCT AVAILABILITY ISSUE 118 0.0052
914 DISCOMFORT 316 0.0052
915 SENSORY DISTURBANCE 83 0.0052
916 EYE PAIN 289 0.0051
917 DRUG INEFFECTIVE 6672 0.0051
918 LIVER INJURY 120 0.0049
919 PANCREATIC CARCINOMA 141 0.0049
920 DEPRESSED MOOD 255 0.0048
921 PELVIC PAIN 87 0.0048
922 ANGIOEDEMA 211 0.0048
923 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 334 0.0047
924 GAMMA-GLUTAMYLTRANSFERASE INCREASED 104 0.0047
925 WHEEZING 274 0.0046
926 MUSCLE TWITCHING 103 0.0045
927 METABOLIC ACIDOSIS 141 0.0044
928 PHOTOPHOBIA 82 0.0044
929 CONVULSION 246 0.0043
930 ILL-DEFINED DISORDER 259 0.0043
931 THROAT TIGHTNESS 115 0.0042
932 MOBILITY DECREASED 302 0.0042
933 GASTRIC CANCER 106 0.0042
934 PRODUCT PRESCRIBING ERROR 99 0.0042
935 FLUSHING 412 0.0040
936 AGITATION 293 0.0040
937 SKIN IRRITATION 182 0.0040
938 DRUG-INDUCED LIVER INJURY 120 0.0038
939 ACCIDENTAL OVERDOSE 138 0.0038
940 ECZEMA 197 0.0038
941 HYPOGLYCAEMIA 181 0.0037
942 EXTRA DOSE ADMINISTERED 151 0.0037
943 ABNORMAL DREAMS 102 0.0037
944 CONDITION AGGRAVATED 1115 0.0037
945 LACTIC ACIDOSIS 117 0.0036
946 PSYCHOTIC DISORDER 105 0.0036
947 INJURY 249 0.0035
948 EYE IRRITATION 202 0.0035
949 RHABDOMYOLYSIS 146 0.0035
950 EPILEPSY 107 0.0035
951 ACNE 265 0.0035
952 PALLOR 94 0.0035
953 COMA 164 0.0034
954 VAGINAL HAEMORRHAGE 147 0.0034
955 PANIC ATTACK 121 0.0033
956 RESPIRATORY ARREST 90 0.0033
957 NIGHTMARE 112 0.0032
958 MIGRAINE 296 0.0031
959 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 170 0.0031
960 PRODUCT USE IN UNAPPROVED INDICATION 765 0.0031
961 SKIN BURNING SENSATION 214 0.0030
962 ANGER 101 0.0030
963 BLADDER CANCER 175 0.0030
964 TYPE 2 DIABETES MELLITUS 99 0.0029
965 EMOTIONAL DISORDER 89 0.0029
966 DYSKINESIA 117 0.0029
967 ANAPHYLACTIC REACTION 156 0.0028
968 DEPRESSED LEVEL OF CONSCIOUSNESS 110 0.0028
969 INJECTION SITE RASH 81 0.0026
970 DRUG EFFECT DECREASED 141 0.0026
971 SURGERY 149 0.0025
972 AGGRESSION 126 0.0025
973 DRUG INTERACTION 320 0.0020
974 NO ADVERSE EVENT 347 0.0019
975 INJECTION SITE REACTION 113 0.0016
976 PRODUCT STORAGE ERROR 136 0.0016
977 MEDICATION ERROR 86 0.0015
978 PSORIASIS 174 0.0013
979 SUICIDAL IDEATION 112 0.0012
980 RHEUMATOID ARTHRITIS 137 0.0012
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 83 0.0012
982 INCORRECT DOSE ADMINISTERED 212 0.0009
983 ACCIDENTAL EXPOSURE TO PRODUCT 90 0.0009
984 OVERDOSE 183 0.0008
985 INJECTION SITE ERYTHEMA 99 0.0008
986 PRODUCT QUALITY ISSUE 105 0.0008
987 EMOTIONAL DISTRESS 91 0.0008
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 82 0.0004